CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Jiangsu Kanion Pharmaceutical Co., Ltd. Company Snapshot
Jiangsu Kanion Pharmaceutical Co., Ltd. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Jiangsu Kanion Pharmaceutical Co., Ltd. with three other companies in this sector in China: Jiangzhong Pharmaceutical Company Limited (2015 sales of 2.60 billion Chinese Renmimbi [US$379.59 million] of which 68% was Medical Industry), Harbin Gloria Pharmaceuticals Co., Ltd (2.70 billion Chinese Renmimbi [US$394.80 million] of which 85% was Pharmaceutical Manufacturing), and Shanghai Shyndec Pharmaceutical Co Ltd (2.68 billion Chinese Renmimbi [US$392.17 million] of which 74% was Drug Products).

Sales Analysis. During the year ended December of 2015, sales at Jiangsu Kanion Pharmaceutical Co., Ltd. were 2.82 billion Chinese Renmimbi (US$412.40 million). This is an increase of 10.0% versus 2014, when the company's sales were 2.56 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Jiangsu Kanion Pharmaceutical Co., Ltd. (and since 2010, sales have increased a total of 108%). Sales of Exportation Trade saw an increase of 10.1% in 2015, from 2.56 billion Chinese Renmimbi to 2.82 billion Chinese Renmimbi. Not all segments of Jiangsu Kanion Pharmaceutical Co., Ltd. experienced an increase in sales in 2015: sales of Other Operations fell 18.3% to 3.51 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Jiangsu Kanion Pharmaceutical Co., Ltd.
  Stock Performance Chart for Jiangsu Kanion Pharmaceutical Co., Ltd.
 
  Stock Data: Recent Stock Performance:
  Current Price (1/20/2017): 16.92
(Figures in Chinese Renmimbi)
1 Week -0.5%   13 Weeks -2.1%  
4 Weeks -9.4%   52 Weeks -1.1%  
 
Jiangsu Kanion Pharmaceutical Co., Ltd. Key Data:
  Ticker: 600557 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 2,820,378,284
(Year Ending Jan 2016).
Employees: 4,305
  Currency: Chinese Renmimbi Market Cap: 10,430,319,127
  Fiscal Yr Ends: December Shares Outstanding: 616,449,121
  Share Type: A Gu Closely Held Shares: 242,951,536
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.